Publications

cemka > Publications

Classer les publications sur l'année

  • Pharmaco-EpidĂ©miologie

    Do two intravenous iron sucrose preparations have the same efficacy?

    ROTTEMBOURG J, KADRI A, LEONARD E, DANSAERT A, LAFUMA A

    Nephrol Dial Transplant ; 2011;26(10):3262-3267

  • Économie de la santĂ©

    A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical

    DEMARTEAU N, DETOURNAY B, TEHARD B, EL HASNAOUI A, STANDAERT B

    Int J Public Health ; 2011;56(2):153-62

  • SantĂ© publique

    Activité physique : une prescription médicale authentique

    NOUVEAU-DUBURCQ A

    2000 - Le Concours MĂ©dical ; Supp. 26 : 20

  • Pharmaco-EpidĂ©miologie

    Impact of rheumatoid arthritis on career progression, productivity, and employability: The PRET Study

    BERTIN P, FAGNANI F, DUBURCQ A, WORONOFF AS, CHAUVIN P, CUKIERMAN G, TROPÉ-CHIROL S, JOUBERT JM, KOBELT G

    Joint Bone Spine ; 2016;83(1):47-52

  • Pharmaco-EpidĂ©miologie

    Identification of patients with gout: elaboration of a questionnaire for epidemiological studies.

    RICHETTE P, CLERSON P, BOUÉE S, CHALÈS G, DOHERTY M, FLIPO RM, LAMBERT C, LIOTE F, POIRAUD T, SCHAEVERBEKE T, BARDIN T.

    Ann Rheum Dis ; 2015;74(9);1684-1690

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Transforming scales of measurement of visual acuity at the group level

    KHOSHNOOD B, MESBAH M, JEANBAT V, LAFUMA A, BERDEAUX G

    Ophthalmic Physiol Opt ; 2010;30(6):816-823

  • Économie de la santĂ©

    The cost of managing HIV infection in highly treatment-experienced, HIV-Infected adults in France

    COLIN X, LAFUMA A, COSTAGLIOLA D, LANG JM, GUILLON P

    Pharmacoeconomics ; 2010;28(S1):59-68

  • SantĂ© publique

    Que retenir du bilan d’ENTRED 2007-2010?

    FAGOT-CAMPAGNA A, WEILL A, PAUMIER A, POUTIGNAT N, FOURNIER C, FOSSE S, ROUDIER C, ROMON I, CHANTRY M, DETOURNAY B, ESCHWEGE E, RUDNICHI A, DRUET C, HALIMI S

    MĂ©decine des Maladies MĂ©taboliques ; 2010;4(2):1-7

  • Pharmaco-EpidĂ©miologie

    Projection de l’incidence du cancer du sein en 2018 en France

    BOUEE S, GROSCLAUDE P, ALFONSI A, FLORENTIN V, CLAVEL-CHAPELON F, FAGNANI F

    Bulletin du Cancer ; 2010;97(3):293-299

  • SantĂ© publique

    PrĂ©vac B: prĂ©vention de l’hĂ©patite B dans les populations migrantes originaires de zones de forte endĂ©mie, Afrique subsaharienne et Asie

    AUBERT JP, CATRICE M, BOUEE S, DI PUMPO A, SANTANA P, GERVAIS A, WAJSBROT A, GELLY J, NOUGAIREDE M

    Revue du Praticien (supplément) ; 2010;60:13-20

  • Pharmaco-EpidĂ©miologie

    Neodymium : YAG laser rates after bilateral implantation of hydrophobic or hydrophilic multifocal intraoculenses : twenty-four month retrospective comparative study

    GAUTHIER L, LAFUMA A, LAURENDEAU C, BERDEAUX G

    J Cataract Refract Surg ; 2010;36(7):1195-1200

  • Économie de la santĂ©

    Modelling the budget impact of Darunavir in the treatment of highly treatment-experienced, HIV-Infected adults in France

    COLIN X, LAFUMA A, COSTAGLIOLA D, SMETS E, MAUSKOPF J, GUILLON P

    Pharmacoeconomics ; 2010;28(S1):183-197

  • Pharmaco-EpidĂ©miologie

    Measurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control : a survey

    NORDMANN JP, BAUDOUIN C, RENARD JP, DENIS P, LAFUMA A, LAURENDEAU C, JEANBAT V, BERDEAUX G

    Clin Ophtalmol ; 2010;4:731-739

  • Économie de la santĂ©

    Lifetime costs and effectiveness of ReSTOR compared with a monofocal IOL and Array-SA40 in the Netherlands

    DE VRIES NE, LAURENDEAU C, LAFUMA A, BERDEAUX G, NUIJTS RM

    Eye ; 2010;24(4):663-672

  • Économie de la santĂ©

    Inpatient costs of endophthalmitis evaluated for the whole of France

    COLIN X, BERDEAUX G, LAFUMA A, SALVANET-BOUCHARA A, KODJIKIAN L

    Appl Health Econ Health Policy ; 2010;8(1):53-60